Parent-Child Interaction Therapy for Disruptive Behaviors
(RAINBOW Trial)
Trial Summary
What is the purpose of this trial?
The RAINBOW study is a fully remote study focused on understanding and treating behavior problems in young children with tuberous sclerosis complex (TSC). The first goal is to enroll a group of 100 children with TSC between the ages of 3 and 6 years old, with and without problem behaviors, to learn about how best to measure behavioral challenges in TSC and how common these behaviors are during this age period. All families will get feedback from the clinical assessments collected. Eligible children who are experiencing behavior problems will be invited to enroll in a pilot clinical trial of internet-based Parent-Child Interaction Therapy (or PCIT), which is meant to help parents better manage their children's challenging behaviors. Adaptations to PCIT are incorporated to suit the needs of TSC children and families. Some participants will be randomly selected to receive the intervention immediately and others after a 6-month delay, but all families will receive the same intervention. Intervention sessions occur on a weekly basis for up to 20 weeks. Follow-up assessments, which include play interactions, parent interviews, and questionnaires occur about 3 and 6 months after the first visit. The delayed treatment group has an extra brief assessment about 12 months from the initial visit. This study will increase what is known about the types of behavior problems that come up during preschool age in TSC and how best to help children and families with TSC who are experiencing these problems.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on behavioral therapy, so it's likely you can continue your medications, but you should confirm with the study team.
What data supports the effectiveness of the treatment Parent-Child Interaction Therapy (PCIT) for disruptive behaviors?
Research shows that Parent-Child Interaction Therapy (PCIT) is effective in treating disruptive behavior problems, hyperactivity, and oppositional-defiant issues in children. It has been studied internationally and found to be beneficial for various behavioral and emotional issues, including conduct problems and child physical maltreatment.12345
Is Parent-Child Interaction Therapy (PCIT) safe for children and parents?
How is Parent-Child Interaction Therapy (PCIT) different from other treatments for disruptive behaviors?
Parent-Child Interaction Therapy (PCIT) is unique because it focuses on improving the parent-child relationship through guided interactions, which helps address disruptive behaviors in young children. Unlike other treatments, PCIT involves real-time coaching of parents to enhance their skills in managing their child's behavior, making it a hands-on and interactive approach.12347
Research Team
Nicole McDonald, PhD
Principal Investigator
University of California, Los Angeles
Eligibility Criteria
This trial is for children aged 3-6 with tuberous sclerosis complex (TSC), both with and without behavior problems. To participate, kids must have a diagnosis of TSC. The study aims to help those struggling with disruptive behaviors by using internet-based therapy tailored for TSC families.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessments of developmental abilities and behavior problems using parent report measures and video recordings
Treatment
Internet-based Parent-Child Interaction Therapy (PCIT) sessions conducted weekly
Follow-up
Participants are monitored for safety and effectiveness after treatment, including play interactions, parent interviews, and questionnaires
Treatment Details
Interventions
- Parent-Child Interaction Therapy (PCIT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Los Angeles
Lead Sponsor